Table 1.
Characteristics of Patients Diagnosed With Malignancy, Sarcoidosis, or Lymphoma
| Final Diagnoses (N = 1136) |
|||
|---|---|---|---|
| Participant Characteristics | Malignancy (n = 61) | Sarcoidosis (n = 59) | Lymphoma (n = 16) |
| Age, mean (SD), y | 67.5 (10.5) | 53.1 (14.6) | 49.2 (19.5) |
| Male sex | 31 (50.8) | 30 (50.9) | 10 (62.5) |
| Nonwhite race | 4 (6.6) | 17 (2.9) | 4 (25.0) |
| Smoking history with at least 10 pack-years | 49 (83.1) | 9 (16.4) | 7 (43.8) |
| Reason for procedure | |||
| Isolated mediastinal lymphadenopathy | 6 (9.8) | 18 (30.5) | 12 (75.0) |
| Lymphadenopathy plus | |||
| Suspicious nodule/mass | 52 (85.3) | 2 (3.4) | 2 (12.5) |
| Parenchymal disease | 3 (4.9) | 39 (66.1) | 2 (12.5) |
| Underlying chronic medical disease | |||
| Coronary artery disease | 10 (16.4) | 5 (8.5) | 3 (18.8) |
| Congestive heart failure | 1 (1.6) | 3 (5.1) | 0 (0) |
| COPD | 26 (42.6) | 4 (6.8) | 1 (6.3) |
| Cerebrovascular accident | 3 (4.9) | 3 (5.1) | 0 (0) |
| Diabetes | 14 (23.0) | 6 (10.2) | 4 (25.0) |
| Prior malignancy | 33 (54.1) | 13 (22.0) | 10 (62.5) |
| Non-small cell lung cancer | 10 (16.4) | 1 (.17) | 0 (0) |
| Small cell lung cancer | 2 (3.3) | 0 (0) | 0 (0) |
| Lymphoma | 1 (1.6) | 3 (5.1) | 9 (56.3) |
| Other solid organ | 19 (31.2) | 8 (13.6) | 1 (6.3) |
| Other | 4 (6.6) | 4 (6.8) | 1 (6.3) |
| Sarcoidosis | 0 (0) | 3 (5.1) | 0 (0) |
| Tuberculosis | 2 (3.3) | 1 (1.7) | 0 (0) |
| Complications | |||
| Bleeding within 48 h | 0 (0) | 0 (0) | 0 (0) |
| Pneumomediastinum within 48 h | 0 (0) | 4 (6.8) | 0 (0) |
| Pneumonia within 10 d | 1 (1.6) | 0 (0) | 0 (0) |
| Pneumothorax within 48 h | 0 (0) | 4 (6.8) | 0 (0) |
| Respiratory failure | 0 (0) | 1 (1.7) | 0 (0) |
| Hemoptysis within 1 wk | 0 (0) | 1 (1.7) | 0 (0) |
Data are presented as n (%) unless otherwise indicated.
COPD, chronic obstructive pulmonary disease.